Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA

Antisense and Nucleic Acid Drug Development

Volumn 11, Issue 4, 2001, Pages 209-217

  Mischiati, C ^a   Jeang, K T ^c   Feriotto, G ^b   Breda, L ^a   Borgatti, M ^a   Bianchi, N ^a   Gambari, R ^a,b  

^a Department of Biochemistry and Molecular Biology ^*  (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMIDINOPHENOXY) 2,2 BIS(4 AMIDINOPHENOXYMETHYL)BUTANE; 1,3 BIS(4 AMIDINOPHENOXY) 2,2 BIS(4 AMIDINOPHENOXYMETHYL)PROPANE; 1,3 BIS(4 AMIDINOPHENOXYMETHYL)PROPANE; AMIDINE; AROMATIC POLYAMIDINE DERIVATIVE; BENZAMIDINE DERIVATIVE; CHLORAMPHENICOL ACETYLTRANSFERASE; HALOGEN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; MOLECULAR INTERACTION; PRIORITY JOURNAL; RNA BINDING; RNA STRUCTURE; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION; VIRUS TRANSCRIPTION;

EID: 0034855264     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729001317022214     Document Type: Article

References (30)

1. The binding mode of drugs to the TAR RNA of HIV-1 studied by electric linear dichroism
2. The search for chemotherapeutic amidines. Part X. Substituted 4:4′-diamidino-αoo-diphenoxyalkanes and -diphenyl ethers
3. Binding of Hoechst 33258 to the TAR RNA of HIV-1. Recognition of a pyrimidine bulge-dependent structure
4. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
5. HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure
6. N1-substituted tetra-benzamidines: Inhibition of DNA-protein interactions and in vitro tumor cell growth
7. Aromatic tetra-amidines: Synthesis of halo-derivatives and their antiproteolitic activity
8. Distamycin inhibits the binding of a nuclear factor to the -278/-256 upstream sequence of the human HLA-DR alpha gene
9. Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen
10. Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNA
11. Cellular transcription factors involved in the regulation of HIV-1 gene expression
12. Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication
13. Multifaceted activities of the HIV-1 transactivator of transcription
14. Control of RNA initiation and elongation at the HIV-1 promoter
15. The regulation of human immunodeficiency virus type-1 gene expression
16. Tetra-p-amidinophenoxypropane as a probe of the specificity site of serine proteases
17. Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells
18. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat
19. DNA binding activity and inhibition of DNA-protein interactions. Differential effects of tetra-p-amidino-phenoxyneopentane and its 2′-bromo derivative
20. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA
21. Molecular cloning and characterization of a TAR-binding nuclear factor from T cells
22. Regulation of HIV-1 transcription
23. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures
24. Structural requirements for trans-activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: Importance of base pairing, loop sequence, and bulges in the tatresponsive sequence
25. Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein
26. Activation of HIV-1 transcription by Tat in cells derived from the CNS: Evidence for the participation of NF-kappa B: A review
27. The search for structure-specific nucleic acid-interactive drugs: Effects of compound structure on RNA versus DNA interaction strength
28. RNA as a drug target: Methods for biophysical characterization and screening